[HTML][HTML] Efficacy of Cytoreductive Surgery (CRS)+ HIPEC in Gastric Cancer with Peritoneal Metastasis: Systematic Review and Meta-Analysis
L Langellotti, C Fiorillo, G D'Annibale, E Panza… - Cancers, 2024 - mdpi.com
Simple Summary Peritoneal disease in gastric cancer has a poor prognosis, with a median
survival of 3–6 months and a 5-year survival rate of 0%. Despite multiple advancements in …
survival of 3–6 months and a 5-year survival rate of 0%. Despite multiple advancements in …